Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pangenomic Health Inc C.NARA

Pangenomic Health Inc. is a precision health company. The Company has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support platform for health practitioners (MUJN... see more

Recent & Breaking News (CSE:NARA)

PanGenomic Health's NARA Debuts New Website, Visual Identity & Natural Wellness E-Commerce Store

Canada NewsWire February 9, 2023

PanGenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility

Canada NewsWire February 2, 2023

PanGenomic Health Announces Intention to Dual List on the UK Aquis Stock Exchange Growth Market

Canada NewsWire January 31, 2023

PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture

Canada NewsWire January 26, 2023

PanGenomic Health's Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

Canada NewsWire January 23, 2023

PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports and Closing of its Non-Brokered Private Placement Offering

Canada NewsWire January 20, 2023

PanGenomic Health's (CSE:NARA) subsidiary launching all-in-one mental health app

Caroline Egan  January 16, 2023

PanGenomic Health's Mindleap App to Expand into an All-In-One App and Telehealth Platform For Holistic Mental Health and Resilience

Canada NewsWire January 16, 2023

PanGenomic Health Subsidiary Signs Partnership with LumiQuick Diagnostics

Canada NewsWire January 12, 2023

PanGenomic Health to Launch E-Commerce Platform for Personalized Natural Health

Canada NewsWire January 9, 2023

PanGenomic Health Retains Capital Markets Advisory Firm

Canada NewsWire January 3, 2023

PanGenomic Health Announces Non-Brokered Private Placement Offering and Closing of First Tranche under Offering

Canada NewsWire December 23, 2022

PanGenomic Health Issues Letter to Shareholders

Canada NewsWire December 22, 2022

Mydecine closes sale of subsidiary, Mindleap Health, to PanGenomic Health (CSE:NARA)

Azuka Onwuka December 12, 2022

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.

GlobeNewswire December 12, 2022

PanGenomic Health Completes Acquisition of Mindleap Health

Canada NewsWire December 12, 2022

PanGenomic Health Enters into Definitive Agreement for Acquisition of Mindleap Health

Canada NewsWire November 21, 2022

PanGenomic Health Appoints Maryam Marissen as CEO

Canada NewsWire September 6, 2022

PanGenomic Health Inc Signs a Non-binding Letter of Intent for the Acquisition of Mindleap Health Inc.

Canada NewsWire September 1, 2022

IIROC Trade Resumption - NARA

Canada NewsWire September 1, 2022